Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Mathias M, Abraham A, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jiménez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pollio B, Sigaud M, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ

Open source

DOI: 10.1111/ejh.14040
Published: 2023 Oct
Container: European journal of haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ejh.14040,
  title = {Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.},
  author = {Mathias M and Abraham A and Belletrutti MJ and Carcao M and Carvalho M and Chambost H and Chan AKC and Dubey L and Ducore J and Gattens M and Gresele P and Gruel Y and Guillet B and Jiménez-Yuste V and Kitanovski L and Klukowska A and Lohade S and Mancuso ME and Oldenburg J and Pollio B and Sigaud M and Vilchevska K and Wu JKM and Jansen M and Belyanskaya L and Walter O and Knaub S and Neufeld EJ},
  year = {2023},
  journal = {European journal of haematology},
  doi = {10.1111/ejh.14040},
  url = {https://doi.org/10.1111/ejh.14040}
}

RIS

TY  - JOUR
TI  - Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
AU  - Mathias M
AU  - Abraham A
AU  - Belletrutti MJ
AU  - Carcao M
AU  - Carvalho M
AU  - Chambost H
AU  - Chan AKC
AU  - Dubey L
AU  - Ducore J
AU  - Gattens M
AU  - Gresele P
AU  - Gruel Y
AU  - Guillet B
AU  - Jiménez-Yuste V
AU  - Kitanovski L
AU  - Klukowska A
AU  - Lohade S
AU  - Mancuso ME
AU  - Oldenburg J
AU  - Pollio B
AU  - Sigaud M
AU  - Vilchevska K
AU  - Wu JKM
AU  - Jansen M
AU  - Belyanskaya L
AU  - Walter O
AU  - Knaub S
AU  - Neufeld EJ
PY  - 2023
JO  - European journal of haematology
DO  - 10.1111/ejh.14040
UR  - https://doi.org/10.1111/ejh.14040
ER  -

APA

M, M., A, A., MJ, B., M, C., M, C., H, C., AKC, C., L, D., J, D., M, G., P, G., Y, G., B, G., V, J., L, K., A, K., S, L., ME, M., J, O., B, P., M, S., K, V., JKM, W., M, J., L, B., O, W., S, K., & EJ, N. (2023). Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.. European journal of haematology. https://doi.org/10.1111/ejh.14040

Source records

pubmed · retrieved 2026-09-26T09:59:20.957Z